Suchergebnisse - "Dahlberg, Suzanne"

PubPharm (12)

1

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma : survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

enthalten in: Nature medicine | 2021

von Forde, P. | Anagnostou, V. | Sun, Z. | +24

2

Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer : Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial

enthalten in: Cancer medicine | 2020

von Steffen McLouth, L. | Zhao, F. | Owonikoko, T. | +12

3

Pemetrexed, Bevacizumab, or the Combination As Maintenance Therapy for Advanced Nonsquamous Non-Small-Cell Lung Cancer : ECOG-ACRIN 5508

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Ramalingam, S. | Dahlberg, S. | Belani, C. | +12

CommentIn: J Clin Oncol. 2020 Mar 1;38(7):770-771. - PMID 31895612

4

Interpretation of Results from Under-accruing Studies

enthalten in: The oncologist | 2018

von Kravets, S. | Dahlberg, S.

CommentOn: Oncologist. 2018 Jul;23(7):859-865. - PMID 29487223

5

Three-arm, randomized, phase 2 study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced non-small cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy : An Eastern Cooperative Oncology Group (ECOG) study (E4508)

enthalten in: Cancer | 2015

von Hanna, N. | Dahlberg, S. | Kolesar, J. | +4

6

Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2013

von Hoang, T. | Dahlberg, S. | Schiller, J. | +1

7

Prognostic models to predict survival in non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin with or without bevacizumab

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2012

von Hoang, T. | Dahlberg, S. | Sandler, A. | +3

8

Randomized phase III study of thoracic radiation in combination with paclitaxel and carboplatin with or without thalidomide in patients with stage III non-small-cell lung cancer : the ECOG 3598 study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2012

von Hoang, T. | Dahlberg, S. | Schiller, J. | +4

CommentIn: J Clin Oncol. 2012 Feb 20;30(6):582-4. - PMID 22271476

9

Sex differences in outcome with bevacizumab therapy : analysis of patients with advanced-stage non-small cell lung cancer treated with or without bevacizumab in combination with paclitaxel and carboplatin in the Eastern Cooperative Oncology Group Trial 4599

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2011

von Brahmer, J. | Dahlberg, S. | Gray, R. | +4

10

Treatment outcomes by tumor histology in Eastern Cooperative Group Study E4599 of bevacizumab with paclitaxel/carboplatin for advanced non-small cell lung cancer

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2010

von Sandler, A. | Yi, J. | Dahlberg, S. | +5

CommentIn: J Thorac Oncol. 2011 Feb;6(2):405. - PMID 21252724